ZA91372B - Oral pharmaceutical forms a pimobendan - Google Patents

Oral pharmaceutical forms a pimobendan

Info

Publication number
ZA91372B
ZA91372B ZA91372A ZA91372A ZA91372B ZA 91372 B ZA91372 B ZA 91372B ZA 91372 A ZA91372 A ZA 91372A ZA 91372 A ZA91372 A ZA 91372A ZA 91372 B ZA91372 B ZA 91372B
Authority
ZA
South Africa
Prior art keywords
pimobendan
oral pharmaceutical
pharmaceutical forms
variations
citric acid
Prior art date
Application number
ZA91372A
Inventor
Peter Gruber
Gruber Peter
Willy Roth
Roth Willy
Gottfried Schepky
Schepky Gottfried
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA91372B publication Critical patent/ZA91372B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pimobendan dosage forms for oral administration contain citric acid, ensuring constantly good absorption even with large pH variations in the gastrointestinal tract.
ZA91372A 1990-01-20 1991-01-18 Oral pharmaceutical forms a pimobendan ZA91372B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001622A DE4001622A1 (en) 1990-01-20 1990-01-20 ORAL DRUGS OF PIMOBENDAN

Publications (1)

Publication Number Publication Date
ZA91372B true ZA91372B (en) 1992-09-30

Family

ID=6398467

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91372A ZA91372B (en) 1990-01-20 1991-01-18 Oral pharmaceutical forms a pimobendan

Country Status (18)

Country Link
EP (1) EP0439030B1 (en)
JP (1) JP2608183B2 (en)
KR (1) KR0163056B1 (en)
AT (1) ATE87481T1 (en)
AU (1) AU630536B2 (en)
CA (1) CA2034569C (en)
DE (2) DE4001622A1 (en)
DK (1) DK0439030T3 (en)
ES (1) ES2054379T3 (en)
FI (1) FI96274C (en)
HK (1) HK175796A (en)
HU (1) HU207948B (en)
IE (1) IE64659B1 (en)
IL (1) IL96995A (en)
NO (1) NO176305C (en)
NZ (1) NZ236834A (en)
PT (1) PT96506B (en)
ZA (1) ZA91372B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753904B1 (en) * 1996-10-01 1998-10-30 Gattefosse Ets Sa PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE OF ACTIVE SUBSTANCE, INCLUDING A MATRIX, AND MANUFACTURING PROCESS
DE102004011512B4 (en) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
JP3996626B2 (en) * 2004-06-22 2007-10-24 塩野義製薬株式会社 Orally disintegrating tablets
JP4572293B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
JP2006028130A (en) * 2004-07-21 2006-02-02 Toa Eiyo Ltd Pimopendan preparation for oral administration
JP4572296B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
WO2007035874A1 (en) * 2005-09-21 2007-03-29 Bristol-Myers Squibb Company Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP4572300B2 (en) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
PE20081482A1 (en) * 2006-12-20 2008-12-23 Novartis Ag GELATINE CAPSULES CONTAINING AN ACID
FR2934156B1 (en) 2008-07-23 2010-09-24 Virbac ORAL ADMINISTRATION MEDICAMENT IN SOLID FORM
WO2010055119A2 (en) * 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
DK2370070T3 (en) 2008-11-25 2013-12-02 Boehringer Ingelheim Vetmed Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats
NL1037569C2 (en) 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
JPWO2011081117A1 (en) * 2009-12-29 2013-05-09 興和株式会社 Solid pharmaceutical composition for oral administration
TW201129557A (en) * 2009-12-29 2011-09-01 Kowa Co Pharmaceutical composition for oral administration
ES2924478T3 (en) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulation of pharmaceutical tablets for the veterinary medical sector, method of production and use thereof
CN105377235A (en) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
AU2014359427B2 (en) * 2013-12-04 2017-04-20 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN106729723A (en) * 2016-11-21 2017-05-31 青岛农业大学 A kind of pharmaceutical composition containing UD-CG115BS.acardi and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837161A1 (en) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K 5-Alkyl:pyridazinyl substd. benzimidazole derivs. - useful as cardiovascular agents, antivirals, interferon inducers and ulcer inhibitors
ES482789A0 (en) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K PROCEDURE FOR THE PREPARATION OF NEW BENZHIMIDAZOLES REPLACED IN POSITION 5 OR 6 WITH A PYRIDAZINONE RING
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS60163823A (en) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd Oral administration pharmaceutical
DE3776269D1 (en) * 1986-11-03 1992-03-05 Schering Corp LABETALOL TABLET WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES.
DE3728244A1 (en) * 1987-08-25 1989-03-09 Thomae Gmbh Dr K Novel (-)-benzimidazoles, their preparation and medicaments containing these compounds
EP0306846A3 (en) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Synergistic combination comprising a phosphodiesterase inhibitor and a thromboxane-a2 antagonist, and its use or preparation
DE3805635A1 (en) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT WITH ANTI-MIXIC EFFECTS ON THE HEART AND ITS COMBINATIONS WITH SS-BLOCKERS OR BRADYCARDICA
JPH01258621A (en) * 1988-04-06 1989-10-16 Fujimoto Seiyaku Kk Dilazep tablet with regulated absorption
JPH023609A (en) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk Long-acting drug preparation containing nicardipine hydrochloride as active component

Also Published As

Publication number Publication date
DE59100067D1 (en) 1993-05-06
HK175796A (en) 1996-09-27
NZ236834A (en) 1995-10-26
EP0439030A2 (en) 1991-07-31
IE64659B1 (en) 1995-08-23
IL96995A0 (en) 1992-03-29
HU207948B (en) 1993-07-28
NO910213L (en) 1991-07-22
CA2034569C (en) 2002-03-19
FI96274C (en) 1996-06-10
JPH04210919A (en) 1992-08-03
EP0439030A3 (en) 1991-10-16
AU6945491A (en) 1991-07-25
ES2054379T3 (en) 1994-08-01
FI910263A0 (en) 1991-01-18
JP2608183B2 (en) 1997-05-07
KR910014120A (en) 1991-08-31
EP0439030B1 (en) 1993-03-31
FI96274B (en) 1996-02-29
ATE87481T1 (en) 1993-04-15
IL96995A (en) 1994-11-11
CA2034569A1 (en) 1991-07-21
HUT56494A (en) 1991-09-30
DK0439030T3 (en) 1993-08-16
NO176305C (en) 1995-03-15
IE910165A1 (en) 1991-07-31
FI910263A (en) 1991-07-21
AU630536B2 (en) 1992-10-29
NO176305B (en) 1994-12-05
NO910213D0 (en) 1991-01-18
PT96506B (en) 1998-06-30
HU910177D0 (en) 1991-08-28
DE4001622A1 (en) 1991-07-25
KR0163056B1 (en) 1998-12-01
PT96506A (en) 1991-10-15

Similar Documents

Publication Publication Date Title
ZA91372B (en) Oral pharmaceutical forms a pimobendan
IT8822379A0 (en) ORAL PHARMACEUTICAL FORMULATIONS WITH SELECTIVE DELIVERY INTO THE COLON.
NO20053106D0 (en) Oral, extended-release analgesic dosage form.
NO912607D0 (en) ORAL, PHARMACEUTICAL DOSAGE FORM WITH PROGRAMMED RELEASE.
ITBO910024A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
DZ1876A1 (en) Medicines for oral administration.
GR3036937T3 (en) Pharmaceutical formulations.
ZA917528B (en) Nasal pharmaceutical composition.
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
GB2214079B (en) Chewable, non-gritty calcium citrate tablet
HK215096A (en) Pharmaceutical formulation containing dirithromycin
HUP0101415A3 (en) 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
ITRM920535A0 (en) PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION THROUGH THE MUCOSA.
IT8583453A0 (en) GROUNDBALL TRANSFER UNIT FOR ROLLING MACHINE, TRANSFER FOR BALLAST AND ROLLING MACHINE EQUIPPED AS SO.
ATE165239T1 (en) ORAL MEDICINAL PREPARATION CONTAINING DICLOFENAC SODIUM AND AN ORGANIC ACID
EP0575583A4 (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals.
NO903130D0 (en) PROCEDURE FOR AA WEEK PRINTED IN A BROWN STREAM.
IS4288A (en) 2,4-disulfonylphenylbutylnitron, its salts, pharmaceutical formulations together with the use of this compound in the manufacture of a medicament
ZA928736B (en) Amino acid derivatives.
MW491A1 (en) Osmotic,oral dosage form for fertility control
IT9021846A1 (en) PRETECTIVE ENVELOPE, PARTICULARLY DESIGNED FOR HOSPITAL USE.
ZW3291A1 (en) Osmotic,oral dosage form for fertility control
ZM1191A1 (en) Osmotic,oral dosage form for fertility control
ATE78405T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PIPERIDINACANOL DERIVATIVES.